SCHEMBL25524265

SCHEMBL25524265

CC1(C)c2ccccc2-c2cc(-c3ccccc3)c(Nc3ccc(-c4ccccc4)cc3)cc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGER4 P35408 1/20 0.37
▸ PDK2 Q15119 3/20 0.35
▸ STK10 O94804 1/20 0.34
▸ SLK Q9H2G2 1/20 0.34
▸ GNG2 P59768 2/20 0.34
▸ GNB1 P62873 2/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ ALOX15 P16050 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ MET P08581 3/20 0.34
▸ HGF P14210 2/20 0.34
▸ MAPKAPK2 P49137 2/20 0.33
▸ MAP3K8 P41279 2/20 0.33
▸ ALK Q9UM73 1/20 0.33
▸ MAPK13 O15264 1/20 0.33
▸ MAPK12 P53778 1/20 0.33
▸ MAPK11 Q15759 1/20 0.33
▸ MAPK14 Q16539 1/20 0.33
▸ EGFR P00533 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29662239 1.00 PTGER4 (0.37) PTGER4PDK2STK10SLKGNG2
SCHEMBL15137673 0.96 PDK2 (0.41) PTGER4PDK2GNG2GNB1CYP1A2
SCHEMBL25570548 0.94 PTGER4 (0.37) PTGER4PDK2STK10SLKGNG2
SCHEMBL26660392 0.94 MAPT (0.37) PDK2CYP1A2CYP2C9ALOX15HSD17B10
SCHEMBL30612824 0.94 MAPT (0.37) PDK2CYP1A2CYP2C9ALOX15HSD17B10
SCHEMBL25125095 0.89 FABP4 (0.40) PDK2KDM4EMEN1ALDH1A1LMNA
SCHEMBL24969287 0.88 PTGER4 (0.35) PTGER4PDK2STK10SLKGNG2
SCHEMBL26900008 0.88 PTGER4 (0.39) PTGER4PDK2STK10SLKMAPKAPK2
SCHEMBL26951736 0.87 RARB (0.46) CYP1A2CYP2C9MEN1ALDH1A1CYP3A4
SCHEMBL26951812 0.87 CYP11B1 (0.33) PTGER4PDK2MAPKAPK2MEN1NFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240215441-A1 ORGANIC LIGHT EMITTING DEVICE LG CHEM, LTD. (KR) 2024-06-27 — — US disclosed
US-20240016055-A1 AMINE-CONTAINING COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE SAME, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE INCLUDING THE ELECTRONIC APPARATUS SAMSUNG DISPLAY CO., LTD. (KR) 2024-01-11 — — US disclosed
CN-117377371-A Amine-containing compound, light-emitting element including the same, electronic device, and electronic apparatus 三星显示有限公司 2024-01-09 — — CN disclosed
WO-2023200226-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME 주식회사 엘지화학 2023-10-19 — — WO disclosed
WO-2023146344-A1 NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME 주식회사 엘지화학 2023-08-03 — — WO disclosed
WO-2023132694-A1 ORGANIC LIGHT-EMITTING DEVICE 주식회사 엘지화학 2023-07-13 — — WO disclosed
CN-116261560-A Compound and organic light emitting device comprising the same 株式会社LG化学 2023-06-13 — — CN disclosed
WO-2023085881-A1 ORGANIC LIGHT-EMITTING DEVICE 주식회사 엘지화학 2023-05-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240016055-A1 AMINE-CONTAINING COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE SAME, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE INCLUDING THE ELECTRONIC APPARATUS SLC1A2, SLC18A1, SAT1 PTGER4 990/4885PDK2 1735/4885STK10 2657/4885
US-20240215441-A1 ORGANIC LIGHT EMITTING DEVICE CRY2, CRY1, AHR PTGER4 1254/4885PDK2 2847/4885STK10 3530/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback